Grifols doesn't grimace when it comes to working with blood. The company provides products and services through three primary divisions: bioscience, diagnostic, and hospital. The bioscience division processes plasma from Grifols' collection centers into therapeutic derivative products such as coagulation factors and trauma products. Its diagnostic division sells testing instruments and reagents for laboratories, including blood bags, separators, incubators, and refrigerators. Grifols provides equipment, software, nutritional products, and IV preparations for hospitals and pharmacies through its hospital division. The firm serves as a holding company for the US operations of Spain-based
Identify and reach decision makers who have been verified by multiple contact methods.
| Executives | Phone/Email |
|---|---|
| Greg Rich CEO |
Premium Access Locked Content
We have executives' phone numbers and email addresses on file. This is optional data available to you when building Lead Lists and with Professional Subscriptions. |
| Joel Abelson President, Commercial Operations |
Premium Access Locked Content
We have executives' phone numbers and email addresses on file. This is optional data available to you when building Lead Lists and with Professional Subscriptions. |
| Mary J. Kuhn President, Manufacturing Operations |
Premium Access Locked Content
We have executives' phone numbers and email addresses on file. This is optional data available to you when building Lead Lists and with Professional Subscriptions. |
| 6 other executives on file | |
| Industries |
|---|
| Biopharmaceuticals & Biotherapeutics Manufacturing |
| Biotechnology Research Services |
| Scientific Research & Development Services |
| 7 Industries on file |
Select key company statistics to target your marketing resources.
View Company Report
| Company Size | |
|---|---|
| Employees | 12,713 |
| Sales (mil) | $1,297.8 |